Trials / Completed
CompletedNCT01398111
Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers
Open-label, Randomized, Single-dose, Placebo-controlled, 4-way Crossover Study to Investigate the Pharmacokinetic Interaction of Glycopyrrolate and Formoterol in Healthy Subjects.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Chiesi Farmaceutici S.p.A. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study will be carried out in healthy volunteers with the primary objective to evaluate the pharmacokinetic interaction between Glyco and Formoterol administered using a pressurised metered dose inhaler (pMDI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glycopyrrolate + Formoterol | glycopyrrolate pMDI + formoterol pMDI |
| DRUG | Glycopyrrolate | glycopyrrolate pMDI |
| DRUG | Formoterol | formoterol pMDI |
| DRUG | Placebo | placebo pMDI |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2011-08-01
- Completion
- 2011-08-01
- First posted
- 2011-07-20
- Last updated
- 2021-10-29
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01398111. Inclusion in this directory is not an endorsement.